Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06865534

Large Language Models to Aid Gynecological Oncology Treatment

This trial aims to assess the impact of providing medical students with access to large language models, in comparison to treatment guideline pdfs, on treatment concordance with a conventional multidisciplinary tumor board

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Institute for Digital Medicine, University Hospital of Giessen and Marburg, Philipps University Marburg

Marburg, 35043, Germany

Location status: Recruiting

Location contact

Johannes Knitza, MD, PhD

CONTACT

[email protected]

+49 (0)6421 586 2589

About this study

Advanced artificial intelligence (AI) technologies, particularly large language models such as OpenAI's ChatGPT, hold significant potential for enhancing medical decision-making. While ChatGPT was not specifically designed for medical applications, it has shown utility in various healthcare scenarios, including answering patient inquiries, drafting medical documentation, and aiding clinical consultations. Despite these advancements, its role in supporting treatment decision-making-particularly in complex oncological cases-remains underexplored.

Treatment decision-making in gynecological oncology is a multifaceted process that integrates evidence-based guidelines, tumor biology, patient-specific factors, and clinical expertise. AI tools like ChatGPT could potentially assist in synthesizing relevant guideline-based recommendations, improving decision accuracy, and facilitating more efficient clinical workflows. However, ChatGPT is not specifically tailored for oncological treatment decisions and lacks comprehensive validation in this domain. Additionally, it may generate misinformation or plausible-sounding but inaccurate recommendations, which could impact clinical judgment. Therefore, understanding how medical professionals, including students and early-career physicians, interact with such AI tools is essential before broader integration into clinical practice. Locally deployable models, such as Llama, enable secure, on-premise usage while retrieval-augmented generation ensures guideline-compliant recommendations.

This study will investigate the impact of language models on treatment decision support for medical students managing gynecological oncology cases. This is a crossover study, where participants will be randomized into two groups. All participants begin with access to ChatGPT for two vignettes. They then proceed with two cases using either a locally deployed language model, followed by two cases relying on guideline PDFs, or vice versa.

Each participant will analyze clinical cases, propose treatment plans, and rate their confidence in their decisions and decision support system usability. This study aims to provide insights into the potential benefits and limitations of integrating AI tools like ChatGPT into oncological treatment decision-making.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Medical students having started with clinical subjects

Exclusion criteria

  • Not being a medical student

Treatment and study plan

Local language model

Other

Group will be given access to local language model first after using ChatGPT and then will get access to pdf file

Guideline pdf

Other

Group will be given access to pdf file after ChatGPT and then to a local language model

Primary outcomes

  1. Treatment concordance with tumor board decisions

    Time frame: directly (within 10 minutes) after Intervention

    Participants in each group select treatment modalities for case vignettes

Secondary outcomes

  1. Treatment confidence

    Time frame: directly (within 10 minutes) after Intervention

    For each case participants will be asked for their treatment confidence (VAS 0-10). The mean score will be compared between decision support groups.

  2. Time spent for treatment decision

    Time frame: directly (within 10 minutes) after Intervention

    Time (in seconds) participants spend per case between the decision support groups will be compared.

Study contacts

Contact information is provided by the study sponsor or research team.

Johannes Knitza, MD PhD

CONTACT

[email protected]

Sebastian Griewing, MD PhD

CONTACT

[email protected]

0049 06421 586 2589

Sponsors and collaborators

Lead sponsor

Philipps University Marburg

Other

Registry information

Official study title

Medical Students and Their Perception of Large Language Models (LLMs) in Gynecologic Oncology

Acronym: EASING

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Mar 10, 2025
Registry last updated
Aug 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.